Company Filing History:
4 out of 1,217 
2 out of 547 
1 out of 3,539 
Years Active: 1993-2010
Title: Len Neckers: Innovator in Anticancer Research
Introduction
Len Neckers is a prominent inventor based in Bethesda, MD, known for his significant contributions to the field of anticancer research. With a total of seven patents to his name, Neckers has focused on developing novel therapeutic agents that target critical pathways in cancer biology.
Latest Patents
Among his latest innovations are the novobiocin analogues, which serve as potential anticancer agents. These novel analogues and derivatives of novobiocin include compounds with modifications to the amide side chain, coumarin ring, and sugar moieties. The compounds developed in this research are particularly useful as heat shock protein 90 inhibitors and may be employed as anticancer and neuroprotective agents.
Career Highlights
Throughout his career, Len Neckers has worked with esteemed organizations, including the United States of America as represented by the Department of Health and the University of Kansas Medical Center Research Institute. His work has significantly advanced the understanding and treatment of cancer.
Collaborations
Neckers has collaborated with notable colleagues such as Jack S Cohen and Cy A Stein, contributing to a rich environment of innovation and research.
Conclusion
Len Neckers continues to be a vital figure in the field of cancer research, with his innovative approaches and collaborations paving the way for future advancements in therapeutic strategies. His work exemplifies the impact of dedicated research on improving health outcomes.